Document is current
Any future updates will be listed below
-
Authors
Jansen, Jan O. https://orcid.org/0000-0001-8863-4398
Pedroza, Claudia
Novelo, Luis Leon
Hao, Tianyao
DeWildt, Gina R.
Coton, Charles F.
Mansoor, Kiran
Stephens, Shannon W.
Marques, Marisa B.
Stubbs, James R.
Richter, Jillian R.
Wang, Henry E.
Holcomb, John B.
DeSantis, Stacia M.
-
Funding
Funding for this research was provided by:
NHLBI (UH3HL157401, U24HL157310)
DOD (HT942523SBAA1)
- License Information
-
More Information
Article History
Received: 30 January 2025
Accepted: 7 July 2025
First Online: 2 August 2025
Declarations
:
: The trial has been approved by Advarra.
: Sample consent forms are included in the appendix. No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results.
: JOJ has received grants from NIH, NIHR, DoD, and MTEC and is a consultant for CSL Behring, Cellphire, Infrascan, and Octapharm. JBH is on the board of directors of CCJ Medical Devices, QinFlow, Hemostatics, and Zibrio; receives research grant support from the DoD, DARPA, NIH, and CSL focused on hemorrhage control and resuscitation. He also consults with WFIRM, Infrascan, Geneva, Aspen Medical and is the co-inventor of the Junctional Emergency Tourniquet Tool and thus receives royalties from UT Health.
